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Abstract: Phosphorylated chitooligosaccharides (P-COS) were prepared using a H3PO4, 
P2O5, Et3PO4 and hexanol solvent system. The P-COS were characterized by Fourier 
Transform Infrared Spectroscopy (FT-IR), Thermo gravimetric-Differential Thermal 
Analyzer (TG-DTA), 
13C NMR, 
31P NMR, X-ray diffraction analysis, solubility studies, 
biocompatibility and Alkaline Phosphatase Activity (ALP). The results reveal that 
phosphorylation occurred at the C3 and C6 position of OH groups and the C2 position of 
NH2 group. FT-IR confirmed no decomposition in pyranose ring in P-COS even with 
heating and treatment in acidic conditions. The amorphous nature of P-COS was confirmed 
by X-ray diffraction analysis. Further, the biocompatibility and alkaline phosphatase 
activity of P-COS were checked against the osteosarcoma MG63 cell line at different 
concentrations and no cytotoxicity was observed. After 12 h and 24 h of incubation, the 
ALP activity of P-COS was higher compared with the control group. These results suggest 
that P-COS is a biocompatible material and in future P-COS could open up a number of 
promising pharmaceutical and clinical applications to mankind.  
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1. Introduction  
Natural polysaccharides are recommended as bioactive materials, because they possess excellent 
properties such as biocompatibility, biodegradability, low-toxicity, adsorption properties, etc. [1]. 
Chitosan is a linear polysaccharide consisting of β-(1→4)-2-acetamido-D-glucose and   
β-(1→4)-2-amino-D-glucose units derived from partial deacetylation of chitin [2-4]. There has been a 
growing interest in chitosan polymer as a promising biomaterial in the pharmaceutical industry in the 
last three decades. However, the poor solubility of chitosan in water makes it too difficult to be used in 
food and biomedical applications [5]. Since the discovery of chitosan, several chemical modifications 
have been tried to improve its solubility and to thus increase its application [6]. Considering this 
limitation, researchers are now concentrating on conversion of chitosan into oligosaccharides [7].  
Chitooligosaccharides (COS) have positive charges with D-glucosamine residues; this property 
enables them to interact with negatively charged polymers, macromolecules and polyanions in an 
aqueous environment [8-9]. COS are readily soluble in water due to their shorter chain lengths and free 
amino groups in D-glucosamine units [1]. COS have been shown to possess many biological activities 
such as antibacterial [7,10-13], immunoenhancing effect [14], as an antioxidant [15-16], matrix 
metalloproteinase (MMP) inhibitors [17-19], anti-diabetic [20], anti-HIV [21], anti-inflammatory [22], 
drug delivery [23], etc. It is believed that the capability of COS is not only restricted to these activities 
and that chemical modifications will enhance and open ways for utilization of COS in various further 
fields [3]. The chemical modifications of COS that have been tried include carboxylation [24], 
phosphorylation [25] and modification with various lipids such as acryloyl, propionyl, butylyl, 
isobutylyl, valeryl, isovaleryl, pivaloyl, hexanoyl, octanoyl, decanoyl, lauroyl, myristoyl, palmitoyl, 
stearoyl, oleoyl, eicosanoyl, docosanoyl, and tetracosanoyl [26]. Compared to natural COS, modified 
COS are found to be more effective in inhibiting angiotensin converting enzymes [24] and potential 
inhibitors of calcium phosphate precipitation [25]. The rationale for this is that chemical modification 
would keep the original physiochemical and biochemical properties of COS and at the same time allow 
out new additional properties [27]. Among the variety of chemical modifications, phosphorylation is 
highly used. Several methods have been used for phosphorylation of chitosan that occurs on the 
surface level, whereas, -H3PO4/P2O5/Et3PO4/hexanol solvent system phosphorylation occurs at the 
molecular level of chitosan with high yield, high degree of substitution and also a simpler purification 
process [27-28]. We propose that use of the same solvent system H3PO4/P2O5/Et3PO4/hexanol for the 
molecular level phosphorylation of COS will increase its potential behavior in   
pharmaceutical applications. 
In this present study, we prepared five different molecular weight P-COS by using the 
H3PO4/P2O5/Et3PO4/hexanol solvent method and named them as S1, S2, S3, S4 and S5. Compared to 
the previously reported strategies for COS modification, this method has several advantages, including 
the mild experimental conditions with no need for purification. Moreover, the cytotoxicity and alkaline J. Funct. Biomater. 2010, 1                    
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phosphatase activity of these five P-COS were examined in human osteoblast-like MG63 cells. These 
results suggest that in the future, P-COS could open up a number of promising pharmaceutical and 
clinical applications to mankind.  
2. Experimental Section  
2.1. Materials 
Five different molecular weight of COS (<1 kDa, 1–3 kDa, 3–5 kDa, 5–10 kDa and >10 kDa) 
prepared from crab shells were purchased from Kitto Life Co. (Seoul, Korea). Hexanol, phosphorus 
pentoxide, phosphoric acid, tri ethyl phosphate, potassium bromide and MTT reagent were obtained 
from Sigma Chemical Co. (St. Louis, MO, USA). Dulbecco’s Modified Eagle’s Medium (DMEM), 
Trypsin-EDTA, penicillin/streptomycin, fetal bovine serum (FBS) and other materials required for 
culturing cells were purchased from Gibco BRL, Life Technologies (USA).  
2.2. Synthesis of P-COS 
Five kinds of P-COS were prepared, according to a previously reported method with slight 
modification [27]. 1.0 g of COS powders were mixed with 10 ml hexanol and a mixture of P2O5 (10 g), 
H3PO4 (5 mL), Et3PO4 (5 mL) was added to the COS solution. Then, the reaction mixture was stirred 
continuously for 72 h at 35 °C. After 72 h, an excess amount of methanol was poured into the reaction 
mixture. The brown color solid product was filtered and then washed with an excess amount of 
methanol. The products were dissolved with double distilled water and then freezed at −80 °C for 5 h 
and lyophilized. The dried products were kept in the desiccator for further analysis.  
2.3. Characterization 
For Thermo gravimetric-differential thermal analysis, COS and P-COS powders were uploaded into 
a Perkin-Elmer (USA) Pyris 1 TGA analyzer. Samples were scanned in a temperature range from 50 to 
700 °C at a constant rate of 10 °C min
−1 with continuous nitrogen flow and DTA curves were obtained. 
The dried samples were mechanically blended with 100 mg of KBr. The mixture was compacted using 
an infrared spectroscopy hydraulic press at a pressure of 8 tons for 60 s. The spectra of samples in the 
form of KBr disks were obtained using a FT-IR spectrometer (Perkin Elmer spectrum GX, 
Beaconsfield Bucks, England) with frequency range 400 cm
−1 to 4,000 cm
−1. For X-ray diffraction 
analysis, the P-COS powders was analyzed through PHILIPS (Netherland), X’Pert-MPD 
diffractometer, at 30 kV and 25 mA, and Cu-Kα radiation (1.5405A°) range 5 to 80° angle at a rate of 
2 °C for 0.1°. The 
13C and 
31P NMR spectra of the P-COS were recorded in D2O on a JNM-ECP-400 
with a JEOL-Japan, 400 MHz spectrometer. Human osteoblast-like MG63 cells were obtained from 
the American Type Culture Collection (Manassas, VA). MG63 cells were grown as previously 
described [29]. In brief, cells were grown in 75 cm
2 plastic tissue culture flasks (Falcon) in DMEM 
medium (Gibco) supplemented with 10% fetal bovine serum, 100 units/mL penicillin and 100 μg/mL 
streptomycin. Cells were maintained at 37 °C in a 95% air, 5% CO2 atmosphere. The culture media 
was changed three times a week. The cell viability of MG63 cells were assessed via   
3-(4,5-dimethyl-2-yl)-2,5-diphenyltetrazolium bromide (MTT) method. The cells were plated at a J. Funct. Biomater. 2010, 1                    
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density of 1 × 10
4 cells/well in 96 well plates. On the following day, the cells were treated with 
different concentrations of P-COS  and incubated for 24 h. The MTT assay relies primarily on 
mitochondrial metabolic capacity of viable cells and reflects the intracellular redox state. After 
incubation, cells were treated with the MTT (Sigma, USA) solution (final concentration, 1 mg/ml) for 
4 h. The medium was removed and 100 µL of DMSO was added to each well. The formazan dye 
crystals were solubilized for 15 min and relative cell viability were determined by measuring the 
absorbance at 570 nm using a GENios microplate reader (Tecan Austria GmbH, Austria). For 
estimation of ALPase activity, osteoblast-like cell were grown to confluence in 24 well plates with 
DMEM containing 5% FBS. The medium was replaced with osteogenic DMEM supplemented with 
phosphorylated chitooligosaccharides and cells were incubated for 12 h and 24 h. After the incubation, 
the cells were rinsed with PBS buffer, homogenized in 25 mM carbonate buffer (pH 10.3) containing 
0.1% Triton X-100. Next, the cellular activity was measured by incubating for 30 minutes at 37 C in 
250 mM carbonate buffer containing 1.5 mM MgCl2 and 15 mM para-Nitro Phenyl Phosphate   
(p-NPP). In the presence of ALP, p-NPP is transformed to p-nitro phenol and inorganic phosphate. The 
ALP activity of the P-COS was determined by measuring the absorbance at 405 nm in   
a spectrophotometer. 
3. Results and Discussion  
3.1. General description 
The color of the P-COS (<1 kDa—S1) sample was found to be pale yellow as compared to other 
molecular weight P-COS (1–3 kDa—S2, 3–5 kDa—S3, 5–10 kDa—S4, and >10 kDa—S5). As the 
molecular weight increases, the color of the product deepens as brownish yellow color. X-ray 
diffraction result reveals that P-COS and COS appeared as amorphous in nature.  
3.2. Solubility of P-COS 
Solubility is the most important factor in pharmaceutical drug development. Solubilities of P-COS 
are shown in Table 1. In this case, we have used 11 type of solvents, P-COS is easily soluble in water, 
hydrochloric acid, dilute acetic acid and sodium hydroxide. However, in the case of organic solvent the 
solubility of P-COS is limited. Based on its solubility in common solvents, we can confirm that P-COS 
is a promising candidate for pharmaceutical drug development. 
Table 1. Solubility of phosphorylated chitooligosaccharides (P-COS). 
Solvent Chitooligosaccharides P-Chitooligosaccharides 
H2O Soluble  Soluble 
Acetic acid (1%)  Soluble  Soluble 
NaOH (1%)  Soluble  Soluble 
HCl (1%)  Soluble  Soluble 
Dimethyl sulfoxide  Soluble  Soluble 
Dimethyl acetamide  Insoluble  Insoluble 
Pyridine Swelling  Swelling 
Dimethyl formamide  Insoluble  Insoluble J. Funct. Biomater. 2010, 1                    
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Table 1. Cont. 
Ethanol Insoluble  Insoluble 
Acetone Insoluble  Insoluble 
Chloroform Insoluble  Insoluble 
 
3.3. Stretching frequency P-COS 
The spectra of unmodified COS and P-COS are shown in Figure 1. The spectrum of unmodified 
COS showed characteristic peaks of amide I at 1,620 cm
−1 and amide II at 1,514 cm
−1. The broad peak 
observed at 3200–3500 cm
−1 is due to the overlapping of different vibrations corresponding to the OH 
and amine groups. The other peaks at 2,890 cm
−1 and 1,380 cm
−1 were assigned to CH stretching and 
CH3 symmetric deformations. The shoulder peaks was observed for P-COS at 1,218 cm
−1, which can 
be attributed to the P=O asymmetric stretching from phosphates. This clearly confirmed that 
phosphorylation occured in the COS moiety. The hydroxyl group absorption in COS was not observed 
at 1,320 cm
−1. This confirmed that phosphorylation occured at all the OH groups of COS [28,30]. 
Figure 1. F T - I R  s p e c t r a  o f  ( a) Chitooligosaccharide (COS; red line) and   
(b) Phosphorylated chitooligosaccharide (P-COS; black line). 
 
 
There was no change in the absorption at 1,147 cm
−1 which indicated that there is no decomposition 
in the pyranose ring of P-COS due to heating and acidic conditions.  
3.4. Thermal stability of P-COS 
The TG-DTA curves of COS and P-COS are shown in Figure 2. Here, no significant differences 
were found between COS and P-COS. The TGA curve of COS showed two different types of peaks at 
100 °C and 200 °C. The first weight loss attributed to loss of water molecule. The second stage weight 
loss observed at 200 °C might correspond to degradation of pyranose ring of COS. In the case of  J. Funct. Biomater. 2010, 1                    
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P-COS, no weight loss was observed at 100 °C, but weight loss was observed at 200 °C, like for COS. 
P-COS loses weight around 80% then compared to unmodified COS (60%). This might corresponds to 
the removal of phosphorylated groups in P-COS. 
Figure 2. TG-DTA curve of (a) TG-chitooligosaccharide (b) TG-P-chitooligosaccharide 
(c) DTA-Chitooligosaccharide (d) TG-P chitooligosaccharide. 
 
 
3.5. 
13C NMR spectra of P-chitooligosaccharide 
Figure 3(a and b) depicts the 
13C NMR spectra of COS (3–5 kDa) and P-COS (3–5 kDa—S3), 
respectively. All the peaks are well separated and correspond to each carbon atom. No other additional 
peaks were observed corresponding to aldehydic and ketonic groups. This revealed that no 
decomposition occurred in pyranose ring. 98.4, 56.0, 70.8, 76.4, 74.8 and 60.2 ppm refers to the C1, 
C2, C3, C4, C5 and C6 positions of COS (3–5 kDa), respectively. Whereas, for P-COS the peaks were 
different from raw 3–5 kDa chitooligosaccharide. The chemical shift of the C6 position moves from 
60.2 to 60.4 ppm and for C-3 from 70.8 to 70.0, indicating the substitution of phosphate group. These 
results indicated that the phosphorylation reaction occurred in chitooligosaccharides. J. Funct. Biomater. 2010, 1                    
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Figure 3. 
13C NMR spectra of (a) chitooligosaccharide (COS), and (b) phosphorylated 
chitooligosaccharide (P-COS). 
 
 
3.6. 
31P NMR spectra of P-chitooligosaccharide 
31P NMR technique is a very good tool to confirm phosphorylated compounds. The 
31P spectra of  
P-COS is shown in Figure 4. The different degrees of substitution and position of phosphorylation in 
COS could be easily identified from the chemical shift of 
31P NMR spectra. Based on 
31P NMR results, 
formation of the phosphate group on COS is considerable and the primary hydroxyl group is more 
reactive than the secondary hydroxyl groups. In addition, the appearance of a small peak around −0.5 
indicated that another kind of group in COS was also phosphorylated. According to Wang et al., if the 
degree of substitution is low we get a single peak, whereas, if the degree of substitution is more we get 
three peaks. This suggested that, the C6 position of hydroxyl group of COS is phosphorylated. Another 
two peaks at −10.8 and −2.7 might be due to phosphorylation at other positions like C2 and C3. The 
low intensity peak observed at −2.7 indicated that one kind of amino group is phosphorylated. 
Figure 4.
. 31P NMR spectra of S3—POS. 
 J. Funct. Biomater. 2010, 1                    
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3.7. Biocompatibility of P-COS in an osteosarcoma–cell line 
The biocompatibility of P-COS was tested against MG63 cells by MTT assay. The results are 
shown in Figure 5 and suggest that chemically modified COS has a potential role in growth of the 
MG63 cell line. No cytotoxicity was observed with different molecular weights of P-COS at the 
concentration of 100 µg/mL and 10 µg/mL. Moreover, with lower molecular weight P-COS, the cells 
proliferated more than with higher molecular weight P-COS; thus the phosphorylated group may 
induce cell proliferation.  
Figure 5. Cytotoxicity effects of the phosphorylated chitooligosaccharides in the MG63 
cell line. The error bar indicates the standard variation of three parallel experiments. 
 
 
3.8. ALP activity of phosphorylated chitooligosaccharides 
ALP activity measurement was carried out to analyze the effect of phosphorylated 
chitooligosaccharides on the osteoblast-like MG63 cell line. The measured ALP activity is shown in 
Figure 6 (low conc. 10 µg/mL, high conc. 100 µg/mL). ALP level was significantly increased in the 
presence of phosphorylated chitooligosaccharides compared to control. However, no significant 
difference was found between the presence of the different molecular weights phosphorylated 
chitooligosaccharides. At 12 h ALP activity of phosphorylated chitooligosaccharides, the absorbance 
at 405 nm was found to be around 0.28, whereas at 24 h, it was found to increase to twice its value at 
12 h (>0.45). J. Funct. Biomater. 2010, 1                    
       
 
11
Figure 6. Alkaline phosphatase activities at 12 and 24 h after treatment of osteoblast-like 
MG63cells with different molecular weight phosphorylated chitooligosaccharides (low 
conc. 10 μg/mL, high conc. 100 μg/mL). The error bars indicate the standard variation of 
three parallel experiments. 
 
 
4. Conclusions 
In the present study, five different molecular weight P-COS were prepared by 
H3PO4/P2O5/Et3PO4/hexanol solvent system. 
31P NMR results suggested that phosphorylation occurs at 
all the reactive positions of COS (at the C2 amino and OH groups at C3 and C6 positions). There is no 
decomposition in P-COS due to the heating and acidic condition, the pyranose ring is very stable and is 
confirmed by infrared spectroscopy. The results suggest that the P-COS lead to no cytotoxicity and an 
increase in the ALP activity on MG63 cell line. It is proposed that low molecular weight P-COS could 
be useful for various biomedical applications. 
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